Panaphix (sodium metaarsenite) / Komipharm - LARVOL DELTA

Did Komipharm abort plan to develop Panaphix as Covid-19 drug? [Google translation] (Korea Biomedical Review) - "Komipharm International said it recently obtained the regulatory approval for a phase-2 clinical trial on Panaphix, an investigational drug, to treat glioblastoma (GBM)...The company had filed the Investigational New Drug (IND) application with the Ministry of Food and Drug Safety in September...The primary endpoint is progression-free survival."

IND • Non-US regulatory • Glioblastoma • Oncology